A Single-Use, In Vitro Biosensor for the Detection of T-Tau Protein, A Biomarker of Neuro-Degenerative Disorders, in PBS and Human Serum Using Differential Pulse Voltammetry (DPV)
Open Access
- 19 February 2017
- journal article
- research article
- Published by MDPI AG in Biosensors
- Vol. 7 (1), 10
- https://doi.org/10.3390/bios7010010
Abstract
A single-use, in vitro biosensor for the detection of T-Tau protein in phosphate-buffer saline (PBS) and undiluted human serum was designed, manufactured, and tested. Differential pulse voltammetry (DPV) served as the transduction mechanism. This biosensor consisted of three electrodes: working, counter, and reference electrodes fabricated on a PET sheet. Both working and counter electrodes were thin gold film, 10 nm in thickness. Laser ablation technique was used to define the size and structure of the biosensor. The biosensor was produced using cost-effective roll-to-roll process. Self-assembled monolayers (SAM) of 3-mercaptopropionic acid (MPA) were employed to covalently immobilize the anti-T-Tau (T-Tau antibody) on the gold working electrode. A carbodiimide conjugation approach using N-(3-dimethylaminopropyl)-N’-ethylcarbodiimide hydrochloride (EDC) and N–hydroxysuccinimide (NHS) cross-linked anti-T-Tau to the carboxylic groups on one end of the MPA. A T-Tau protein ladder with six isoforms was used in this study. The anti-T-Tau concentration used was 500,000 pg/mL. The T-Tau protein concentration ranged from 1000 pg/mL to 100,000 pg/mL. DPV measurements showed excellent responses, with a good calibration curve. Thus, a practical tool for simple detection of T-Tau protein, a biomarker of neuro-degenerative disorders, has been successfully developed. This tool could also be extended to detect other biomarkers for neuro-degenerative disorders, such as P-Tau protein and β-amyloid 42.Keywords
This publication has 29 references indexed in Scilit:
- Early Detection of Amyloidopathy in Alzheimer's Mice by Hyperspectral EndoscopyInvestigative Ophthalmology & Visual Science, 2016
- T-Tau and P-Tau in Brain and Blood from Natural and Experimental Prion DiseasesPLOS ONE, 2015
- Hyperspectral Imaging Signatures Detect Amyloidopathy in Alzheimer’s Mouse Retina Well before Onset of Cognitive DeclineACS Chemical Neuroscience, 2014
- Clinicopathologic assessment and imaging of tauopathies in neurodegenerative dementiasAlzheimer's Research & Therapy, 2014
- Identification of common variants influencing risk of the tauopathy progressive supranuclear palsyNature Genetics, 2011
- Cerebrospinal fluid and plasma biomarkers in Alzheimer diseaseNature Reviews Neurology, 2010
- Diffusion-weighted brain imaging study of patients with clinical diagnosis of corticobasal degeneration, progressive supranuclear palsy and Parkinson's diseaseBrain, 2008
- Tau as a biomarker of neurodegenerative diseasesBiomarkers in Medicine, 2008
- Tauopathies: classification and clinical update on neurodegenerative diseases associated with microtubule‐associated protein tauInternal Medicine Journal, 2006
- Decreased β-Amyloid1-42and Increased Tau Levels in Cerebrospinal Fluid of Patients With Alzheimer DiseaseJAMA, 2003